Company

RNAssist

Biotechnology Research Cambridge, Cambridgeshire, United Kingdom 3 employees

Employees: 3

rnassist.com LinkedIn

RNAssist Overview

Headquarters: Cambridge, Cambridgeshire, United Kingdom
Website: rnassist.com
Industry: Biotechnology Research
Employees: 3
Founded: 2012
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

RNA and LNP vaccine stabilisation thermostabilisation mRNA vaccine and therapeutics cell stabilisation scRNA-seq multiomics biomolecule stabilisation tissue fixation protein stabilisation microbial viability LNP potency and biodistribution

About RNAssist

Our flagship stabilization solutions — TheraPHIX™, vivoPHIX™, genoPHIX™, virusPHIX™ and virusPHIX-P9™ — are designed for a wide range of applications within life sciences and therapeutics. vivoPHIX™ leverages advanced molecular stabilization technology to ensure sample integrity during tissue fixation, dissociation, and single-cell workflows, including scRNA-seq and CITE-seq. virusPHIX™ facilitates virus inactivation and secure transport, preserving molecular fidelity for improved diagnostic accuracy and high-quality data generation. For mRNA-LNP vaccine and therapeutic thermostabilization TheraPHIX™ improves stability and potency in the form an ambient stable injectable liquid formulation.